Product Information

PIOGLITAZONE-METFORMIN 15-500 is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2940 per EA under NDC 65862052560. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Feb 13, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PIOGLITAZONE-METFORMIN 15-500

Pioglitazone Hydrochloride and Metformin Hydrochloride
$0.2940per EA

Strength

500; 15 mg/1; mg/1

NDC

65862052560

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA200823

FDA Approved

2/13/2013

TE Code

AB

On Market Since

2/13/2013

Pharmacological Classes

Biguanide
Biguanides
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE-METFORMIN 15-500 has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 87.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2940 per EA
All-time high$2.4539 (Feb 12, 2014)
All-time low$0.1994 (Apr 19, 2023)
52-week high$0.4151
52-week low$0.2835
Median price$0.7538
Average price$0.9558
Largest weekly change+79.1% (Apr 17, 2024)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+3.7%

3M

-21.9%

6M

-23.0%

1Y

-34.1%

3Y

-45.0%

5Y

-29.7%

All

-87.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE-METFORMIN 15-500?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE-METFORMIN 15-500, manufactured by Aurobindo Pharma Limited, is $0.2940 per EA (NDC 65862052560), effective Nov 11, 2026.

How has the price of PIOGLITAZONE-METFORMIN 15-500 changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE-METFORMIN 15-500 has declined 87.0%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE-METFORMIN 15-500?

Since Nov 28, 2013, the NADAC for PIOGLITAZONE-METFORMIN 15-500 has ranged from a low of $0.1994 (Apr 19, 2023) to a high of $2.4539 (Feb 12, 2014), with a median of $0.7538 per EA.

Are there cheaper alternatives to PIOGLITAZONE-METFORMIN 15-500?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PIOGLITAZONE-METFORMIN 15-500 in a comparable dosage form, but none are currently priced below it.

Who manufactures PIOGLITAZONE-METFORMIN 15-500?

PIOGLITAZONE-METFORMIN 15-500 (NDC 65862052560) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.